BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Trichostatin A
,
rs2300478
,
GATA1
,
T cell receptor signaling pathway
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MLN-518
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
NR1D1
FAM111A
Ugt2b37
RRM2
USP2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
BERENJENO_TRANSFORMED_BY_RHOA_UP
GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP
GOLDRATH_ANTIGEN_RESPONSE
GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Livers of rat exposed to variety of hepatotoxic compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent…
Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding ca…
LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic …
Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug…
CCT245718, a dual FLT3/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
Study of Milnacipran for the Treatment of Fibromyalgia
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Lan…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ